Skip to main content
Log in

Aggressive Lymphomas Diagnosed in the Bone Marrow: Two Illustrative Cases

  • Case Report
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Lymphomas with subtle patterns in the marrow can be a diagnostic challenge, unless a high index of suspicion is maintained. We present two patients with aggressive lymphomas who presented with cytopenias and the subsequent bone marrow examinations yielded surprising results. These cases highlight the potential usefulness of a bone marrow examination in the diagnosis of lymphomas in the absence of nodal or other tissue specimens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Foucar K, Reichard K, Czuchlewski D (2010) Bone marrow pathology, 3rd edn. ASCP Press, Chicago

    Google Scholar 

  2. Swerdlow SH, International Agency for Research on Cancer., World Health Organization (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours, 4th edn. International Agency for Research on Cancer, Lyon

    Google Scholar 

  3. Ferreri AJ, Dognini GP, Campo E, Willemze R, Seymour JF, Bairey O, Martelli M, De Renz AO, Doglioni C, Montalban C, Tedeschi A, Pavlovsky A, Morgan S, Uziel L, Ferracci M, Ascani S, Gianelli U, Patriarca C, Facchetti F, Dalla Libera A, Pertoldi B, Horvath B, Szomor A, Zucca E, Cavalli F, Ponzoni M (2007) Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica 92(4):486–492

    Article  PubMed  Google Scholar 

  4. Morice WG, Rodriguez FJ, Hoyer JD, Kurtin PJ (2005) Diffuse large B-cell lymphoma with distinctive patterns of splenic and bone marrow involvement: clinicopathologic features of two cases. Mod Pathol 18(4):495–502. doi:10.1038/modpathol.3800297

    Article  PubMed  Google Scholar 

  5. Yegappan S, Coupland R, Arber DA, Wang N, Miocinovic R, Tubbs RR, Hsi ED (2001) Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol 14(11):1147–1156. doi:10.1038/modpathol.3880450

    Article  CAS  PubMed  Google Scholar 

  6. Ponzoni M, Arrigoni G, Gould VE, Del Curto B, Maggioni M, Scapinello A, Paolino S, Cassisa A, Patriarca C (2000) Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 31(2):220–226

    Article  CAS  PubMed  Google Scholar 

  7. Shimada K, Matsue K, Yamamoto K, Murase T, Ichikawa N, Okamoto M, Niitsu N, Kosugi H, Tsukamoto N, Miwa H, Asaoku H, Kikuchi A, Matsumoto M, Saburi Y, Masaki Y, Yamaguchi M, Nakamura S, Naoe T, Kinoshita T (2008) Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 26(19):3189–3195. doi:10.1200/JCO.2007.15.4278

    Article  CAS  PubMed  Google Scholar 

  8. Bazhenova L, Higginbottom P, Mason J (2006) Intravascular lymphoma: a role for single-agent rituximab. Leuk Lymphoma 47(2):337–341. doi:10.1080/10428190500300837

    Article  CAS  PubMed  Google Scholar 

  9. Ponzoni M, Ferreri AJ, Campo E, Facchetti F, Mazzucchelli L, Yoshino T, Murase T, Pileri SA, Doglioni C, Zucca E, Cavalli F, Nakamura S (2007) Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol 25(21):3168–3173. doi:10.1200/JCO.2006.08.2313

    Article  PubMed  Google Scholar 

  10. Farcet JP, Gaulard P, Marolleau JP, Le Couedic JP, Henni T, Gourdin MF, Divine M, Haioun C, Zafrani S, Goossens M et al (1990) Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 75(11):2213–2219

    CAS  PubMed  Google Scholar 

  11. Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124–4130. doi:10.1200/JCO.2008.16.4558

    Article  PubMed  Google Scholar 

  12. Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M (2007) Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 44(2):265–267. doi:10.1097/MPG.0b013e31802f6424

    Article  PubMed  Google Scholar 

  13. Chen YH, Chadburn A, Evens AM, Winter JN, Gordon LI, Chenn A, Goolsby C, Peterson L (2011) Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-/CD8-gammadelta T-cell large granular lymphocytic leukemia. Am J Clin Pathol 136(2):289–299. doi:10.1309/AJCPTFFQ18JMYKDF

    Article  CAS  PubMed  Google Scholar 

  14. Tripodo C, Iannitto E, Florena AM, Pucillo CE, Piccaluga PP, Franco V, Pileri SA (2009) Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol 6(12):707–717. doi:10.1038/nrclinonc.2009.169

    Article  PubMed  Google Scholar 

  15. Foppoli M, Ferreri AJ (2014) Gamma-delta t-cell lymphomas. Eur J Haematol. doi:10.1111/ejh.12439

    PubMed  Google Scholar 

  16. Belhadj K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R, Deconinck E, Charlotte F, Leblond V, Labouyrie E, Lederlin P, Emile JF, Delmas-Marsalet B, Arnulf B, Zafrani ES, Gaulard P (2003) Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102(13):4261–4269. doi:10.1182/blood-2003-05-1675

    Article  CAS  PubMed  Google Scholar 

  17. Nosari A, Oreste PL, Biondi A, Costantini MC, Santoleri L, Intropido L, Muti G, Pungolino E, Gargantini L, Morra E (1999) Hepato-splenic gammadelta T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome. Am J Hematol 60(1):61–65. doi:10.1002/(SICI)1096-8652(199901)60:1<61:AID-AJH10>3.0.CO;2-L

    Article  CAS  PubMed  Google Scholar 

  18. Gaulard P, Belhadj K, Reyes F (2003) Gammadelta T-cell lymphomas. Semin Hematol 40(3):233–243 (S0037196303001379)

    Article  PubMed  Google Scholar 

  19. Schafer E, Chen A, Arceci RJ (2009) Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant. Pediatr Blood Cancer 53(6):1127–1129. doi:10.1002/pbc.22129

    Article  PubMed  PubMed Central  Google Scholar 

  20. Weidmann E (2000) Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 14(6):991–997

    Article  CAS  PubMed  Google Scholar 

  21. Mittal S, Milner BJ, Johnston PW, Culligan DJ (2006) A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab. Eur J Haematol 76(6):531–534. doi:10.1111/j.1600-0609.2006.00646.x

    Article  CAS  PubMed  Google Scholar 

  22. Jaeger G, Bauer F, Brezinschek R, Beham-Schmid C, Mannhalter C, Neumeister P (2008) Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine. Ann Oncol 19(5):1025–1026. doi:10.1093/annonc/mdn119mdn119

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rekha Bhat.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhat, R., Pai, S., Das, K. et al. Aggressive Lymphomas Diagnosed in the Bone Marrow: Two Illustrative Cases. Indian J Hematol Blood Transfus 32 (Suppl 1), 125–129 (2016). https://doi.org/10.1007/s12288-015-0520-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-015-0520-7

Keywords

Navigation